Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-11 Sale | 2024-11-13 4:49 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan President, Research & Develop. | 4,109 | $20.03 | $82,300 | 160,888 (Direct) | View |
| 2024-11-11 Sale | 2024-11-13 4:47 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 8,637 | $19.98 | $172,562 | 111,006 (Direct) | View |
| 2024-11-04 Sale | 2024-11-06 4:36 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan President, Research & Develop. | 18,219 | $18.62 | $339,281 | 164,997 (Direct) | View |
| 2024-10-16 Sale | 2024-10-18 4:31 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan President, Research & Develop. | 600 | $18 | $10,800 | 183,216 (Direct) | View |
| 2024-09-26 Sale | 2024-09-30 4:32 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 847 | $16 | $13,552 | 125,149 (Direct) | View |
| 2024-09-09 Sale | 2024-09-10 4:34 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 3,195 | $14.97 | $47,832 | 76,486 (Direct) | View |
| 2024-09-06 Sale | 2024-09-10 4:33 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 2,303 | $15.09 | $34,753 | 125,996 (Direct) | View |
| 2024-09-06 Sale | 2024-09-10 4:32 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 3,242 | $15.12 | $49,004 | 183,816 (Direct) | View |
| 2024-08-16 Sale | 2024-08-20 4:33 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 27,097 | $16.27 | $440,801 | 194,938 (Direct) | View |
| 2024-07-12 Sale | 2024-07-16 4:43 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 1,238 | $18 | $22,284 | 188,814 (Direct) | View |
| 2024-07-12 Sale | 2024-07-16 4:42 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 1,900 | $17.84 | $33,897 | 334,475 (Direct) | View |
| 2024-07-08 Sale | 2024-07-10 4:34 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 1,758 | $14.95 | $26,282 | 81,412 (Direct) | View |
| 2024-06-13 Sale | 2024-06-14 4:32 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 1,000 | $16.17 | $16,174 | 336,375 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 5:26 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 18,980 | $15.16 | $287,695 | 190,052 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 5:21 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 3,000 | $15.04 | $45,129 | 337,375 (Direct) | View |
| 2024-05-14 Purchase | 2024-05-16 4:33 pm | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 25,000 | $14.59 | $364,673 | 92,412 (Direct) | View |
| 2024-05-08 Purchase | 2024-05-10 4:35 pm | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 4,476 | $14.14 | $63,306 | 67,412 (Direct) | View |
| 2024-04-08 Purchase | 2024-04-10 4:35 pm | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 2,600 | $13.57 | $35,290 | 62,936 (Direct) | View |
| 2024-03-28 Purchase | 2024-04-01 4:31 pm | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 1,512 | $13.75 | $20,794 | 60,336 (Direct) | View |
| 2024-03-22 Purchase | 2024-03-26 5:57 pm | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 9,048 | $13.58 | $122,882 | 58,824 (Direct) | View |
| 2024-03-19 Purchase | 2024-03-21 4:31 pm | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 2,732 | $12.81 | $34,996 | 49,776 (Direct) | View |
| 2024-03-06 Sale | 2024-03-08 4:36 pm | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 4,086 | $12.31 | $50,285 | 74,170 (Direct) | View |
| 2024-03-06 Sale | 2024-03-08 4:34 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 1,826 | $12.32 | $22,499 | 137,204 (Direct) | View |
| 2024-02-15 Sale | 2024-02-20 4:37 pm | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 1,000 | $15 | $15,000 | 243,279 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-11 Exercise | 2024-11-13 4:47 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 6,000 | $0 | 111,006 (Direct) | View |
| 2024-11-11 Exercise | 2024-11-13 4:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 6,000 | $2.1 | 111,006 (Direct) | View |
| 2024-09-05 Tax Withholding | 2024-09-05 6:49 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 826 | $15.13 | 325,753 (Direct) | View |
| 2024-09-03 Tax Withholding | 2024-09-05 6:49 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 72 | $17.7 | 325,753 (Direct) | View |
| 2024-09-03 Tax Withholding | 2024-09-05 6:49 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 2,328 | $15.76 | 325,753 (Direct) | View |
| 2024-09-04 Tax Withholding | 2024-09-05 6:49 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 4,744 | $15.42 | 325,753 (Direct) | View |
| 2024-09-03 Tax Withholding | 2024-09-05 6:49 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 752 | $16.93 | 325,753 (Direct) | View |
| 2024-09-05 Tax Withholding | 2024-09-05 6:48 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 171 | $15.13 | 128,299 (Direct) | View |
| 2024-09-03 Tax Withholding | 2024-09-05 6:48 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 15 | $17.7 | 128,299 (Direct) | View |
| 2024-09-03 Tax Withholding | 2024-09-05 6:48 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 483 | $15.76 | 128,299 (Direct) | View |
| 2024-09-04 Tax Withholding | 2024-09-05 6:48 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 983 | $15.42 | 128,299 (Direct) | View |
| 2024-09-03 Tax Withholding | 2024-09-05 6:48 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 156 | $16.93 | 128,299 (Direct) | View |
| 2024-09-05 Tax Withholding | 2024-09-05 6:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 167 | $15.13 | 187,058 (Direct) | View |
| 2024-09-03 Tax Withholding | 2024-09-05 6:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 14 | $17.7 | 187,058 (Direct) | View |
| 2024-09-03 Tax Withholding | 2024-09-05 6:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 469 | $15.76 | 187,058 (Direct) | View |
| 2024-09-04 Tax Withholding | 2024-09-05 6:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 955 | $15.42 | 187,058 (Direct) | View |
| 2024-09-03 Tax Withholding | 2024-09-05 6:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 151 | $16.93 | 187,058 (Direct) | View |
| 2024-09-05 Tax Withholding | 2024-09-05 6:46 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 165 | $15.13 | 79,681 (Direct) | View |
| 2024-09-03 Tax Withholding | 2024-09-05 6:46 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 14 | $17.7 | 79,681 (Direct) | View |
| 2024-09-03 Tax Withholding | 2024-09-05 6:46 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 462 | $15.76 | 79,681 (Direct) | View |
| 2024-09-04 Tax Withholding | 2024-09-05 6:46 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 941 | $15.42 | 79,681 (Direct) | View |
| 2024-09-03 Tax Withholding | 2024-09-05 6:46 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 149 | $16.93 | 79,681 (Direct) | View |
| 2024-08-16 Exercise | 2024-08-20 4:33 pm | N/A 2029-12-10 | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 20,000 | $0 | 194,938 (Direct) | View |
| 2024-08-16 Exercise | 2024-08-20 4:33 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 20,000 | $1.74 | 194,938 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:39 pm | N/A 2034-06-13 | Entrada Therapeutics Inc. | TRDA | PARMAR KUSH Director 10% Owner | 16,000 | $0 | 16,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:38 pm | N/A 2034-06-13 | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:36 pm | N/A 2034-06-13 | Entrada Therapeutics Inc. | TRDA | Thistle Mary Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:34 pm | N/A 2034-06-13 | Entrada Therapeutics Inc. | TRDA | Zeiher Bernhardt G Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 4:33 pm | N/A 2034-06-13 | Entrada Therapeutics Inc. | TRDA | Chapman Gina Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-05 4:31 pm | N/A 2032-06-02 | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 11,918 | $0 | 104,330 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-05 4:31 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | KIM PETER S Director | 11,918 | $6.06 | 104,330 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-19 4:33 pm | N/A 2030-11-10 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 9,000 | $0 | 126,327 (Direct) | View |
| 2024-03-15 Exercise | 2024-03-19 4:33 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 9,000 | $2.1 | 126,327 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:48 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 1,164 | $12.42 | 498,875 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:48 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 1,391 | $13.37 | 498,875 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 7:48 pm | N/A 2034-03-01 | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 263,200 | $0 | 498,875 (Direct) | View |
| 2024-03-05 Tax Withholding | 2024-03-05 7:48 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Doshi Dipal CEO | 5,049 | $12.28 | 498,875 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 339 | $12.42 | 125,056 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 405 | $13.37 | 125,056 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 7:47 pm | N/A 2034-03-01 | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 77,700 | $0 | 125,056 (Direct) | View |
| 2024-03-05 Tax Withholding | 2024-03-05 7:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | WENTWORTH KORY JAMES Chief Financial Officer | 1,471 | $12.28 | 125,056 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:46 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 343 | $12.42 | 189,130 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:46 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 409 | $13.37 | 189,130 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 7:46 pm | N/A 2034-03-01 | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 143,200 | $0 | 189,130 (Direct) | View |
| 2024-03-05 Tax Withholding | 2024-03-05 7:46 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J President & COO | 1,486 | $12.28 | 189,130 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:44 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 347 | $12.42 | 275,832 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:44 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 414 | $13.37 | 275,832 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 7:44 pm | N/A 2034-03-01 | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 110,900 | $0 | 275,832 (Direct) | View |
| 2024-03-05 Tax Withholding | 2024-03-05 7:44 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 1,505 | $12.28 | 275,832 (Direct) | View |